Kerry Stokes’ Media Executives Invest in Orthocell
Seven West Media has shown notable interest in ASX-listed medtech company Orthocell, a Perth-based firm specializing in cell regeneration therapies. Orthocell was established in 2007 after being spun out from the University of Western Australia and currently holds a market capitalization fluctuating around $300 million.
Over the past year, Orthocell’s value has increased approximately 80%, reflecting its steady progress. Despite this growth, Orthocell remains one among many small medtech companies listed on the ASX.
About Orthocell
- Founded in 2007, spun out of the University of Western Australia
- Specializes in cell regeneration therapies
- Market capitalization around $300 million
- Stock value grew roughly 80% in the last year
“Most people wouldn’t have heard of Orthocell.”
Orthocell’s profile gains attention as part of Seven West Media’s broader coverage and investment interests in emerging medical technology companies.
Note to Investors
Orthocell is one of many small medical technology companies on the ASX, attracting interest from media executives and investors alike.
Stay informed by following topics, people, and companies that align with your interests.
Author’s summary: Seven West Media’s focus on Perth-based Orthocell reveals growing media and investor attention toward promising but lesser-known ASX medtech companies.